Virginia Oncology Associates

Williamsburg, Virginia 23188

3 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Castration-Resistant Prostate Cancer, Melanoma, Metastatic Breast Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma of the Head and Neck, Triple Negative Breast Cancer

Studies at this site

• Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now
• A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer — Recruiting now
• Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors — Completed
• Breast Cancer Index (BCI) Registry — Running, not enrolling
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• Triple Negative Breast Cancer Biomarker Study — Completed